Human developmental biology of granulocyte colony-stimulating factor

Clinics in Perinatology

Volumn 27, Issue 3, 2000, Pages 559-576

  Calhoun, Darlene A ^a   Christensen, Robert D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;

AMNION FLUID; BREAST MILK; CLINICAL TRIAL; HUMAN; INFECTION; LUNG LAVAGE; NEUTROPENIA; NONHUMAN; PLACENTA; PRIORITY JOURNAL; REVIEW; SERUM; UMBILICAL CORD BLOOD; URINE;

EID: 0033837417     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(05)70039-7     Document Type: Article

References (122)

1. Neutopenia in the neonate
2. Stimulatory effects of epidermal growth factor on deoxyribonucleic acid synthesis in the gastrointestinal tract of the suckling mouse
3. Serum tumor necrosis factor-alpha in neonatal sepsis
4. Molecular analysis of the granulocyte colony-stimulating factor receptor
5. Human granulocyte colony-stimulating factor: Biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines
6. Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery
7. Erythropoietin, given enterally, stimulates erythropoiesis in premature infants
8. UK multicentre prospective, randomised, double-blind, placebo-controlled trial of rhG-CSF (granulocyte colony-stimulating factor) in neonatal sepsis
9. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in early neonatal sepsis
10. Enhancement of intestinal growth in neonatal rats by epidermal growth factor in milk
11. Enhancement of neonatal somatic and hepatic growth by orally administered epidermal growth factor in rats
12. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis
13. Congenital neutropenia and the risk of leukemia
14. Development of luminal protein digestion: Implications for biologically active dietary polypeptides
15. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in amniotic fluid and in tracheal aspirates
16. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate
17. Review of G-CSF and GM-CSF: Effects on neonatal neutrophil kinetics
18. Prophylactic or simultaneous administration of recombinant human granulocyte colony-stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats
19. Seven day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: Modulation of neonatal neutrophilia, myelopoiesis, and group B streptococcus sepsis
20. Decreased G-CSF and IL-3 production and gene expression from mononuclear cells of newborns
21. The distribution of granulocyte colony-stimulating factor receptor (G-CSF-R) and its messenger RNA expression in the human fetus
22. A randomized, double-blind, placebo controlled pilot trial of recombinant granulocyte colony-stimulating factor administration in women prior to preterm delivery
23. Assessment of the contribution of the spleen to granulocytopoiesis and erythropoiesis of the mid-gestation human fetus
24. Granulocyte colony-stimulating factor (G-CSF) and its receptor (G-CSF-R) at the maternal-fetal interface
25. Concentrations of granulocyte colony-stimulating factor in human milk after in vitro simulations of digestion
26. Granulocyte colony-stimulating factor (G-CSF) is present in human milk and its receptor (G-CSF-R) is present in human fetal intestine
27. Granulocyte colony-stimulating factor (G-CSF) serum and urine concentrations in neutropenic neonates before and following the intravenous administration of recombinant G-CSF
28. The concentration of granulocyte colony-stimulating factor (G-CSF) in amniotic fluid
29. Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery
30. The effects of maternal phlebotomy and orally-administered erythropoietin (Ep) on erythropoiesis in the sucking rat
31. Effects of hormone erythropoietin in milk on erythropoiesis in neonatal rats
32. Granulocyte colony-stimulating factor and its receptor
33. Expression of colony-stimulating factor genes by normal human mesothelioma cell lines in vitro
34. Defective hematopoiesis and vasculogenesis in transforming growth factor B-1 knock out mice
35. Mutations in the gene for the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia
36. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia
37. A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukemia results in the overexpression of a novel G-CSF-R isoform
38. Administration of recombinant human granulocyte colony-stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta 2 integrin expression
39. Tumor necrosis factor downregulates granulocyte colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes
40. The role of polymorphonuclear neutrophils in clearance of granulocyte colony-stimulating factor in vivo and in vitro
41. Comparison of interleukin 1 production by adherent cells and tissue pieces from human placenta
42. Expression cloning of a receptor for murine granulocyte colony-stimulating factor
43. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor
44. Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections
45. A randomized, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: Significant induction of peripheral and bone marrow neutrophilia
46. Human milk contains granulocyte colony stimulating factor
47. Intrapartum treatment of acute chorioamnionitis: Impact upon neonatal sepsis
48. Effects of prematurity onthe immunologic system in human milk
49. Premature labor and intra-amniotic infection
50. Elevated IgA concentration in milk produced by mothers delivered of preterm infants
51. Digestion in the newborn
52. Amniotic fluid granulocyte colony stimulating factor levels in chorioamnionitis do not predict neonatal sepsis
53. Human milk feedings and infection among very low birth weight infants
54. The in situ expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA at the maternal-fetal interface
55. The expression and localization of interleukin-1B mRNA in chorioamnionitis
56. Levels of serum granulocyte colony-stimulating factor in patients with infections
57. Granulocyte colony-stimulating factor as a marker for bacterial infection in neonates
58. Human milk as a potential enteral source of erythropoietin
59. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged pre-eclampsia associated neutropenia
60. Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factor
61. Pharmacokinetics and pharmacodynamics of a recombinant human granulocyte colony-stimulating factor
62. High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates
63. Maternal rescue of transforming growth factor-B1 null mice
64. Production of granulocyte colony-stimulating factor by the human placenta at various stages of development
65. Production of interleukin-6 by fetal and maternal cells in vivo during intra-amniotic infection and in vitro after stimulation with interleukin-1
66. Production of granulocyte colony-stimulating factor by a human melanoma cell line
67. Breast milk and neonatal necrotizing entercolitis
68. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants
69. Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta
70. Expression of granulocyte colony-stimulating factor and its receptor is regulated during the development of the human placenta
71. Granulocyte colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis
72. The granulocyte-macrophage colony-stimulating factors
73. Purification of a granulocyte colony-stimulating factor from the conditioned medium of a subclone of human bladder carcinoma cell line 5637, HTB9
74. Antimicrobial properties of preterm breast milk cells
75. Using granulocyte colony-stimulating factor for neutropenia during neonatal sepsis
76. Granulocyte colony-stimulating factor and its receptor
77. Granulocyte colony-stimulating factor receptor and its related receptors
78. Tyrosine kinase JAK1 is associated with the granulocyte colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation
79. Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cells
80. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells: Identification as granulocyte colony-stimulating factor (G-CSF)
81. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while B IL-3 receptor-deficient mice are normal
82. Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection
83. A randomized double-blind, placebo-controlled trial of granulocyte colony stimulating factor administration to treat neonatal neutropenia
84. Neutrophil pool sizes and granulocyte colony-stimulating factor production in human mid-trimester fetuses
85. Contribution of granulocyte- (G) and granulocyte macrophage-(GM) colony stimulating factor (CSF) to airway inflammation in infants who develop chronic lung disease (CLD)
86. Apparent role of the macrophage colony-stimulating factor-1, in placental development
87. Granulocyte colony-stimulating factor in amniotic fluid
88. Hematopoietic and lung abnormalities in mice with a nullmutation of the common B subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5
89. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor
90. Amniotic fluid interleukin-6 in preterm labor
91. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition
92. Tumor necrosis factor in term and preterm labor
93. Amniotic fluid interleukin-1 in spontaneous labor at term
94. Granulocyte colony-stimulating factor treatment for neonatal neutropenia
95. Origin of macrophage colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor (G-CSF) in amniotic fluid
96. Expression of granulocyte colony-stimulating factor and its receptor at the fetomaternal interface in murine and human pregnancy
97. Amniotic fluid granulocyte colony-stimulating factor in preterm and term labor
98. Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates
99. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis
100. Seeds A: Current concepts of amniotic fluid dynamics
101. Mice lacking both granulocyte colony-stimulating factor (CSF) and granlocyte macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long term survival
102. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets
103. Location of the G-CSF gene on chromosome 17 proximal to the breakpoint in the t(15;17) in acute promyelocytic leukemia
104. Hematopoiesis in the liver and marrow of human fetuses at 5 to 16 weeks postconception: Quantitative assessment of macrophage and neutrophil populations
105. Cytokine production and visualized effects in the feto-maternal unit: Quantitative and topographic data on cytokines during intrauterine disease
106. Augmentation of fetal granulopoiesis with chorioamnionitis during the second trimester of gestation
107. Pharmacokinetics of intravenous recombinant human granulocyte colony-stimulating factor in children receiving myelosupressive cancer chemotherapy: Clearance increases in relation to absolute neutrophil count with repeated dosing
108. Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder
109. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction
110. Gastrointestinal absorption of epidermal growth factor in suckling rats
111. Granulocyte colony-stimulating factor in cord blood of premature neonates born to mothers with pregnancy induced hypertension
112. Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells
113. Cytokines in human breast milk
114. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay
115. Pharmacokinetic studies of intravenous glycosylated recombinant human granulocyte colony-stimulating factor in various hematological disorders: Inverse correlation between half-life and bone marrow myeloid cell pool
116. G-CSF, GM-CSF, and IL-6 levels in cord blood: Diminished increase of G-CSF and IL-6 in preterms with perinatal infection compared to term neonates
117. Purification and biochemical characterization for human pluripotent hematopoietic colony-stimulating factor
118. Does breast milk protect against septicaemia in the newborn?
119. Breast milk feeding in very low birthweight infants
120. Vascular endothelial cells and granulopoiesis: Interleukin-1 stimulates release of G-CSF and GM-CSF